Black Rose Industries Limited has commenced the remote e-voting process to seek shareholder approval for the re-appointment of two Whole-time Directors, Mr. Ambarish Daga and Mrs. Shruti Jatia. The voting period began on July 7, 2026, at 9:00 a.m. IST and will conclude on August 5, 2026, at 5:00 p.m. IST. The company has engaged National Securities Depository Limited (NSDL) to facilitate the e-voting, and no physical ballot forms will be accepted.

The Board of Directors approved the resolutions based on the recommendations of the Nomination and Remuneration Committee. The re-appointments are subject to the approval of members. Mr. Ambarish Daga, designated as an Executive Director, has over 25 years of experience in corporate operations, finance, and operations management. Mrs. Shruti Jatia, also designated as an Executive Director, brings over three decades of experience in finance, accounts, and business operations.

Mr. Shiv Hari Jalan, Proprietor of Shiv Hari Jalan & Co., has been appointed as the Scrutinizer to ensure the e-voting process is conducted fairly and transparently. The results of the postal ballot will be announced not later than two working days after the conclusion of e-voting. The notice and explanatory statement were sent to members electronically via email on July 6, 2026.

Shareholders whose names appear in the Register of Members or Register of Beneficial Owners as on the cut-off date of July 3, 2026, are eligible to participate. The company has requested shareholders to update their KYC details, bank mandates, and nomination information as part of the "Saksham Niveshak" campaign conducted by the Investor Education and Protection Fund Authority (IEPFA).

Key Details of the Proposed Re-appointments

Black Rose Industries Ltd. announced its financial results for the fiscal year 2025-26, reporting a 7.34% year-on-year increase in Profit After Tax (PAT) to ₹224.96 million. The company's revenue from operations for the year stood at ₹3258.38 million. EBITDA for the period grew by 8.27% to ₹354.33 million, driven by operational efficiencies and a favourable product mix. The company declared a dividend of 125% for the financial year.

Financial Performance

The company's standalone financials for the full year show a decline in revenue from operations by 4.36% to ₹3258.38 million from ₹3406.85 million in the previous year. However, profitability metrics improved significantly. EBITDA margins expanded to 11.0% in FY26 from 9.7% in FY25. PAT margins also improved to 7.0% from 6.3% in the corresponding period of the previous year.

Segmental Performance

The business presence is divided into chemical distribution and chemical manufacturing. The manufacturing segment demonstrated strong growth, with revenue increasing to ₹1141 million in FY26 from ₹948 million in FY25. EBITDA for this segment rose to ₹251 million from ₹172 million. The distribution segment reported revenue of ₹2091 million, a decrease from ₹2431 million in the previous year, with EBITDA at ₹173 million compared to ₹210 million.

Balance Sheet and Ratios

The company's net worth increased to ₹1692.8 million in FY26 from ₹1526.5 million in FY25. Total debt reduced significantly, bringing the debt-to-equity ratio down to 0.01 from 0.06 in the previous year. Return on Capital Employed (ROCE) improved to 18.24% from 17.89%, while Return on Equity (ROE) stood at 13.29% compared to 13.90% in FY25.

Business Outlook

For the current quarter, the company expects domestic demand for acrylamide liquid to pick up in the second half. The outlook for chemical distribution focuses on new product additions and expanding the end-user customer base. The company is also advancing its PAM solid project to the piloting stage and developing new downstream acrylamide products to diversify its portfolio. The Specialty amines project, undertaken along with Koei Chemicals Company, is progressing as planned.